retatrutide fda approval status 2025 Weight Loss Results:Trial Data and FDA approves Retatrutide this year?

Retatrutide (LY3437943) is an investigational triple incretin receptor agonist being evaluated in clinical trials for obesity and type 2 diabetes

Sharma A, Ambrosy AP, DeVore AD, Margulies KB, McNulty SE, Mentz RJ, Hernandez AF, Michael Felker G, Cooper LB, Lala A

Just one

Introduce the diluent slowly down the inner glass wall, never directly onto the lyophilised cake, and swirl gently until fully dissolved

What Happens When You Stop GLP-1 Medications If you're taking a GLP-1 medication like Wegovy or Saxenda for weight management, there's a good chance you've thought about what happens when you eventually stop

*If we're unable to treat you, we'll provide a full refund